Every 30 minutes, someone arrives at an ER with a gunshot wound, according to the CDC
The COVID-19 pandemic and its corresponding increase in shootings sparked a national conversation around firearm injury, emergency room visits, and the treatment of gun violence victims in hospitals. Five years later, the conversation has faded, but new data from the Centers for Disease Control and Prevention shows that gun violence remains a stubborn presence across the country, with 93,022 shooting injuries treated in hospitals from 2018 to 2023.
According to the research, an American emergency room treats at least one firearm injury every 30 minutes.
'Most cities use police data to inform prevention planning, but data from hospital and public health sources is an essential, and often missing, piece to guide action, as many incidents of violence and crime are not reported to police,' said Dr. Adam Rowh, a medical epidemiologist at the CDC and lead author of the study, via e-mail to The Trace.
The study, published in Annals of Internal Medicine in April, analyzed the CDC's data on emergency department firearm injuries, which is limited to the District of Columbia and nine states: Florida, Georgia, New Mexico, North Carolina, Oregon, Utah, Virginia, Washington, and West Virginia. The study showed that the monthly rates for shooting injuries were highest in July and lowest in February; daily rates were disproportionately high on holidays, and nighttime peaks were the highest on Friday and Saturday, consistent with prior research. The researchers also found that rates were highest between 2:30 a.m. and 3 a.m., and were the lowest between 10 a.m. and 10:30 a.m.
The authors of the study concluded that knowing the periods when gunshot injuries are highest could be essential both in deploying care and in effectively allocating resources, such as trauma preparedness, ambulance services, hospital staffing, and strategies for intervention.
One of those strategies is hospital-based violence intervention programs (HVIPs), an effort aimed at mitigating reinjury by providing holistic and rehabilitative care to shooting victims. The model, first developed 30 years ago, has spread nationwide, and various programs fund their services through myriad resources, most notably through grants now facing the threat of cuts and closures.
'It's happening on every front,' January Serda, the grant coordinator of one such program in Newport News, Virginia, said of federal cuts to community violence intervention funding, education, and healthcare.
Dr. Randi Smith, a trauma surgeon who launched an HVIP at Grady Memorial Hospital, in Atlanta, said she has attended to a gunshot victim on every one of her on-call days in the trauma center. Financial and social investment in such programs is as paramount to treatment as life-saving medical care, she emphasized.
'I was very motivated to start a violence intervention program, taking best practices from some of the programs that I have been a part of and shortcomings that I had learned from the past,' Smith said. The program she started in 2023, Interrupting Violence Among Youth and Young Adults, is one of the few based in the Southeast.
The program has served more than a thousand people, including survivors and their family members. According to Smith, its reinjury rates are less than 3 percent, compared with national benchmarks that are up to 30 percent and institutional benchmarks that are between 12 percent and 15 percent.
Her work has a long legacy. Nearly four decades ago, physicians and nurses—especially those with public health experience—were among the first cohort of medical practitioners to recognize gun violence as a public health issue. That recognition was largely based on what they witnessed in hospitals and emergency rooms, as the rate of shootings reached historic highs in the 1980s and 1990s. Those firsthand accounts were pivotal in the development of the nation's first hospital-based violence intervention programs.
Serda, the grant coordinator for an HVIP in Virginia, said in today's multilayered crisis, it's more paramount than ever to prioritize care for the people on the frontlines. She came to violence intervention from nonprofit management and fundraising for survivors of sexual assault in 2022, after her 17-year-old son, Justice Dunham, was fatally shot in a high school parking lot after a basketball game.
'I was blown away by the lack of training around trauma-informed care, or safe spaces and outlets, for nurses and practitioners, and people who are seeing this firsthand and helping the community,' said Serda, who began to advocate for trauma-informed initiatives designed to help patients, her HVIP team and others address the emotional impact of caring for victims of violence and firearm injuries. 'There was no discussion about compassion fatigue, burnout, or vicarious trauma.'
As hospital personnel adjust to the ever-evolving firearm violence crisis, Smith said listening to their experiences, and supporting their well-being, has never been more crucial.
'I think a lot of people are looking at the recent news, post-pandemic, that shootings have decreased, and have not realized that we as hospital staff are still treating patients day after day,' said Smith, 'dealing with a medical environment that shifted significantly since the pandemic, and navigating extreme burnout.'
This story was produced by The Trace and reviewed and distributed by Stacker.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CNN
22 minutes ago
- CNN
CDC vaccine advisers to vote on thimerosal in flu shots at first meeting of new panel
Vaccines Federal agencies Respiratory viruses Children's healthFacebookTweetLink Follow A newly posted agenda for next week's meeting of the just-appointed group of outside vaccine advisers to the US Centers for Disease Control and Prevention includes a discussion and vote on thimerosal in flu vaccines, a preservative tied to debunked claims from decades ago of links to autism. The meeting, scheduled to start June 25 and run for two days, is the first for a newly installed group of eight Advisory Committee on Immunization Practices members. US Health and Human Services Secretary Robert F. Kennedy Jr. dismissed the previous group of 17 experts last week, claiming that they had conflicts of interest. A number of the new panelists, though, have raised concerns from the public health world for their positions on vaccines, including serving as expert witnesses in lawsuits against vaccine makers and suggesting without evidence that Covid-19 vaccines kill young people and should immediately be removed from the market. It's not clear what the discussion and vote at next week's meeting on thimerosal in flu vaccines will entail, and the presenter of the information at the meeting is listed on the agenda as 'TBD.' A spokesperson for HHS directed questions about the nature of the discussion and vote back to the posted agenda. Thimerosal is a mercury-based compound used to prevent bacteria and fungus from growing in vaccines, and the CDC says data from multiple studies 'show no evidence of harm caused by the low doses of thimerosal in vaccines.' Nonetheless, the use of thimerosal in vaccines has declined significantly since the US Food and Drug Administration in 1999 asked vaccine manufacturers to detail plans to remove it; the FDA now says 'all vaccines routinely recommended for children 6 years of age and younger in the U.S. are available in formulations that do not contain thimerosal.' The preservative is still used in some multidose vials of seasonal flu vaccines. Since thimerosal was largely removed from pediatric vaccines, autism rates have continued to rise, which the CDC notes 'is the opposite of what would be expected if thimerosal caused autism.' Thimerosal has long been a focus of Kennedy, who published a book in 2014 called 'Thimerosal: Let the Science Speak,' referring to it as 'mercury, a known neurotoxin.' The CDC points out, however, that there are two kinds of mercury – methylmercury and ethylmercury – and high levels of the first can be toxic to people. Thimerosal contains ethylmercury, the agency says, 'which is cleared from the human body more quickly than methylmercury, and is therefore less likely to cause any harm.' The fact that thimerosal is now on the agenda of Kennedy's newly appointed vaccine advisers suggests they may publicly claim, against evidence, that the preservative is dangerous, said Dr. Paul Offit, a vaccine scientist at Children's Hospital of Philadelphia and an outside vaccine adviser to the FDA. 'All that's going to do is make it so that those vaccines will become less available and more expensive,' Offit told CNN. 'It certainly won't make them safer.' Offit pointed out that reformulating those vaccines couldn't be done quickly by manufacturers, so it would 'most likely just lead to vaccine shortages and make the vaccines more expensive.' Also new to the agenda is a discussion and proposed recommendations for the measles, mump, rubella and varicella (or chickenpox) vaccine for children under 5. It's not clear what the nature of that discussion will be either, and its presenters are also listed as 'TBD.' The combination vaccine, known as MMRV, has been approved in the US as ProQuad since 2005, and the CDC notes that while the combination vaccine has one fewer injection than the individual shots, it's associated with a higher risk for fever and febrile seizures five to 12 days after the first dose among children between 1 and 2 years old. Administering the varicella vaccine separately from the MMR vaccine avoids this increased risk, which the CDC points out is 'very low for both options.' Although it's not clear whether that will be the focus of the presentation and recommendations, Offit noted that vaccine advisers have already had that discussion, so 'I'm not sure what's going to be added here.' The meeting had been scheduled to take place over three days, according to a June 9 posting in the Federal Register, and now has been shortened to two. It still includes votes on RSV immunization for pregnant women and children and in the Vaccines for Children program, as well as planned discussions on Covid-19, chikungunya and anthrax vaccines, but the topic list has been significantly slimmed down. No longer included are discussions on cytomegalovirus vaccine, human papillomavirus (HPV) vaccine, Lyme disease vaccine, meningococcal vaccine and pneumococcal vaccines. At an internal meeting Tuesday among CDC employees, a member of leadership told staffers that some agenda items for the upcoming ACIP meeting might not be included because they were still bringing new members up to speed, according to a CDC employee who requested anonymity for fear of reprisal. The employee called that reasoning 'a transparent lie; they wouldn't have had to bring all these new people up to speed if they hadn't fired the old ones.' The agenda also includes a number of 'TBD' listings for presenters, including on the safety of Covid-19 vaccines and RSV immunizations. At previous meetings, those presentations on Covid-19 have been made by Dr. Fiona Havers and Dr. Lakshmi Panagiotakopoulos, who both resigned in the past few weeks, citing concerns about changes to the CDC's vaccine processes under Kennedy. 'My career in public health and vaccinology started with a deep-seated desire to help the most vulnerable members of our population,' Panagiotakopoulos wrote in an email to former ACIP members, obtained by CNN, 'and that is not something I am able to continue doing in this role.'
CNN
24 minutes ago
- CNN
Former leader of anti-vaccine group founded by RFK Jr. to present at first meeting of new CDC vaccine advisers
Vaccines Disability issues Federal agencies Children's healthFacebookTweetLink Follow A former leader of the anti-vaccine group Children's Health Defense will present this week on thimerosal in flu vaccines at a meeting of the newly appointed vaccine advisers to the US Centers for Disease Control and Prevention, according to a CDC official with knowledge of the decision who wasn't authorized to reveal the information. The presenter, Lyn Redwood, is a nurse practitioner with experience in pediatrics and family medicine, according to a bio posted on Children's Health Defense's website, which notes she is president emerita of the organization. She previously served as president of the World Mercury Project in 2016, which 'expanded its mission' two years later to become Children's Health Defense, which was founded by US Health and Human Services Secretary Robert F. Kennedy Jr. Thimerosal is a preservative used in vaccines to prevent microbial growth, but it was removed from most shots decades ago because of concerns that it contains a form of mercury. Subsequent studies showed thimerosal - which contains ethylmercury, a form that's cleared from the body much more quickly than methylmercury, the kind found in some fish - wasn't linked to neurodevelopmental issues, including autism. Nonetheless, it became a key focus of groups, like Children's Health Defense, that argue vaccines are linked to autism. The addition of a discussion and vote at this week's meeting on thimerosal in flu vaccines — it's still included in some multidose vial forms — led to concerns from the public health community that those debunked links would be brought up again, after Kennedy dismissed all 17 former members of the Advisory Committee on Immunization Practices and replaced them with eight new members. Two of the new members served as expert witnesses in trials against vaccine makers, and a third claims, against evidence, that Covid-19 vaccines contributed to the deaths of young people. Most flu vaccines given to children now come in single-dose vials or pre-filled syringes which don't contain thimerosal. Some multi-dose vials, which account for about 4% of the flu vaccines given in the US, still contain it. Experts said they found the inclusion of the topic on the ACIP agenda puzzling. 'I actually don't know any pediatric practices that even use that multi-dose influenza vaccine anyway,' said Dr. Sean O'Leary, a pediatrician at Children's Hospital Colorado and liaison to ACIP for the American Academy of Pediatrics. Redwood's scheduled presentation to the CDC vaccine advisory committee is unusual. Typically, presenters are members of the ACIP working groups who have spent months gathering and discussing evidence on a given topic. The vote on thimerosal was added days ago and it's not clear what the discussion and vote on thimerosal in flu vaccines will entail. Reached by phone, Redwood declined to comment about her upcoming presentation. Redwood's history with vaccines appears thoroughly intertwined with concerns about the safety of thimerosal and ties to neurodevelopmental disorders including autism, which multiple studies have since determined are not linked. In 1999, Children's Health Defense notes, Redwood 'calculated that her son had received 125 times the EPA Federal Safety guidelines for safe mercury exposure from his infant vaccines resulting in a diagnosis of autism.' Redwood has since coauthored papers and testified before Congress about the issue. Redwood is among the 'mercury moms' who pushed for Kennedy to get involved with mercury and children's health. Children's Health Defense, which describes its mission as 'ending childhood health epidemics by eliminating toxic exposures,' recently held an event called 'the Autism Cover-Up,' billed as an expose of a coverup by the CDC, US Food and Drug Administration and others of a link between vaccines and autism. Redwood was a speaker about thimerosal. The CDC says data from multiple studies 'show no evidence of harm caused by the low doses of thimerosal in vaccines.' Nonetheless, the use of thimerosal in vaccines has declined significantly since the US Food and Drug Administration in 1999 asked vaccine manufacturers to detail plans to remove it. The FDA now says 'all vaccines routinely recommended for children 6 years of age and younger in the U.S. are available in formulations that do not contain thimerosal.' This is a breaking news story and will be updated.
CNN
24 minutes ago
- CNN
Former leader of anti-vaccine group founded by RFK Jr. to present at first meeting of new CDC vaccine advisers
A former leader of the anti-vaccine group Children's Health Defense will present this week on thimerosal in flu vaccines at a meeting of the newly appointed vaccine advisers to the US Centers for Disease Control and Prevention, according to a CDC official with knowledge of the decision who wasn't authorized to reveal the information. The presenter, Lyn Redwood, is a nurse practitioner with experience in pediatrics and family medicine, according to a bio posted on Children's Health Defense's website, which notes she is president emerita of the organization. She previously served as president of the World Mercury Project in 2016, which 'expanded its mission' two years later to become Children's Health Defense, which was founded by US Health and Human Services Secretary Robert F. Kennedy Jr. Thimerosal is a preservative used in vaccines to prevent microbial growth, but it was removed from most shots decades ago because of concerns that it contains a form of mercury. Subsequent studies showed thimerosal - which contains ethylmercury, a form that's cleared from the body much more quickly than methylmercury, the kind found in some fish - wasn't linked to neurodevelopmental issues, including autism. Nonetheless, it became a key focus of groups, like Children's Health Defense, that argue vaccines are linked to autism. The addition of a discussion and vote at this week's meeting on thimerosal in flu vaccines — it's still included in some multidose vial forms — led to concerns from the public health community that those debunked links would be brought up again, after Kennedy dismissed all 17 former members of the Advisory Committee on Immunization Practices and replaced them with eight new members. Two of the new members served as expert witnesses in trials against vaccine makers, and a third claims, against evidence, that Covid-19 vaccines contributed to the deaths of young people. Most flu vaccines given to children now come in single-dose vials or pre-filled syringes which don't contain thimerosal. Some multi-dose vials, which account for about 4% of the flu vaccines given in the US, still contain it. Experts said they found the inclusion of the topic on the ACIP agenda puzzling. 'I actually don't know any pediatric practices that even use that multi-dose influenza vaccine anyway,' said Dr. Sean O'Leary, a pediatrician at Children's Hospital Colorado and liaison to ACIP for the American Academy of Pediatrics. Redwood's scheduled presentation to the CDC vaccine advisory committee is unusual. Typically, presenters are members of the ACIP working groups who have spent months gathering and discussing evidence on a given topic. The vote on thimerosal was added days ago and it's not clear what the discussion and vote on thimerosal in flu vaccines will entail. Reached by phone, Redwood declined to comment about her upcoming presentation. Redwood's history with vaccines appears thoroughly intertwined with concerns about the safety of thimerosal and ties to neurodevelopmental disorders including autism, which multiple studies have since determined are not linked. In 1999, Children's Health Defense notes, Redwood 'calculated that her son had received 125 times the EPA Federal Safety guidelines for safe mercury exposure from his infant vaccines resulting in a diagnosis of autism.' Redwood has since coauthored papers and testified before Congress about the issue. Redwood is among the 'mercury moms' who pushed for Kennedy to get involved with mercury and children's health. Children's Health Defense, which describes its mission as 'ending childhood health epidemics by eliminating toxic exposures,' recently held an event called 'the Autism Cover-Up,' billed as an expose of a coverup by the CDC, US Food and Drug Administration and others of a link between vaccines and autism. Redwood was a speaker about thimerosal. The CDC says data from multiple studies 'show no evidence of harm caused by the low doses of thimerosal in vaccines.' Nonetheless, the use of thimerosal in vaccines has declined significantly since the US Food and Drug Administration in 1999 asked vaccine manufacturers to detail plans to remove it. The FDA now says 'all vaccines routinely recommended for children 6 years of age and younger in the U.S. are available in formulations that do not contain thimerosal.' This is a breaking news story and will be updated.
